UNICON Business Summary

UNICON Optical Co., Ltd. (4150.TWO) is a leading Taiwanese medical device manufacturer specializing in the research, development, and mass production of soft hydrophilic contact lenses. The company generates revenue through a dual-track model consisting of its proprietary UNICON brand and extensive OEM/ODM services for global partners. Its high-density product portfolio is segmented into daily and monthly disposables, cosmetic color lenses, and advanced silicone hydrogel and multi-focal variants, supported by manufacturing facilities in Hsinchu Science Park and Taichung. UNICON distinguishes itself through vertically integrated capabilities in material science and automated mold design, maintaining critical certifications such as EU MDR (CE), US FDA, and Japanese FMA. Within the competitive landscape, UNICON ranks as a top-tier regional player alongside domestic peers like St. Shine Optical, Pegavision, and Visco Vision, positioning itself as a specialized, high-agility alternative to global incumbents such as Alcon and CooperVision. Founded in 1992, the company is currently led by Chairman and General Manager Ming-Zheng Lin, who oversees strategic direction and operational execution. The leadership team includes key directors such as Hui-Sen Hu and Representative Director Chi-Yeung Ng, who joined the board in 2024 to bolster international market expansion. UNICON’s governance is supported by independent directors like Wen-Wan Tang and a stable institutional shareholder base including Jun He Technology Co., Ltd. and Youxiang Investment Co., Ltd. This executive core leverages over three decades of technical pedigree in the Hsinchu optoelectronics ecosystem to drive innovation in drug-release lens technology and high-oxygen permeability materials, ensuring the firm remains a critical node in the global vision care supply chain.